Both in Diagnostics
Achieve Life Sciences vs Intellia Therapeutics
Over the past year ACHV returned +45.1% and NTLA returned +0.9%; their daily moves had a correlation of 0.30.
ACHV +45.1% NTLA +0.9%Growth of $1, one year, split-adjusted
| Metric | ACHV | NTLA |
|---|---|---|
| Price | $6.98 | $12.31 |
| Market cap | $719.7M | $1.72B |
| Today | +3.71% | +3.79% |
| 1 month | −0.7% | −0.5% |
| 6 months | +45.4% | −11.1% |
| Year to date | +40.4% | +36.9% |
| 1 year | +36.6% | −5.8% |
| Revenue growth (YoY) | — | −46.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −1392.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 29.0× |
| Net cash | $172.4M | $437.8M |
| Dividend yield | — | — |
| Volatility (60d) | 60.5% | 63.0% |
| Short % of float | 28.1% | 38.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).